New laser and synchrotron upgrades promise stronger UK research capabilities, even as funding pressures lead to shorter operating cycles and reduced access at some facilities.

Oxford-based OMass Therapeutics has raised £230 million to advance its clinical pipeline, highlighting the role of native mass spectrometry in discovering treatments for rare disorders.

Stockport NHS Foundation Trust’s blood science laboratory has achieved My Green Lab Gold certification after changes to daily workflows addressing energy use and single-use plastics.

A bespoke high-throughput platform cut optimisation from weeks to hours and increased productivity fivefold, while automation also improves powder handling and routine laboratory data management.

A trial of engineered regulatory T cells for severe autoimmune conditions has advanced to its second dose cohort, highlighting progress in cell-therapy research and delivery.

Sustainability in LC-MS is most often discussed in terms of solvent consumption, and for good reason. Liquid chromatography relies heavily on mobile phases, frequently containing acetonitrile or methanol, which must be manufactured, transported, stored and eventually disposed of as chemical waste.